Clinical and serological features of 35 patients with anti-Ki autoantibodies

Abstract

The objective of this study was to analyse clinical and serological associations of anti-Ki antibodies. Thirty-five patients with anti-Ki antibodies, detected by CIE, selected from laboratory routine, were studied. All patients were affected by autoimmune diseases: SLE and pSS were the most frequent diagnoses. The cohort was constituted by 27 female and eight males. Main clinical features were skin involvement (60%), xerophtalmia (48.6%), Raynaud’s phenomenon (43%), photosensitivity (34%), xerostomia (31.4%). CNS involvement was present in four (11.4%) and renal disease in seven cases (20%). ANA, anti-dsDNA and RF were detected in 100%, 60% and 34.5%. In SLE, anti-Ki was detected in 6% of cases, more frequently in males compared to other SLE patients without anti-Ki (P < 0.004). Nineteen anti-Ki positive patients affected by SLE showed more frequently malar rash and multiple autoantibody specificities compared to 16 anti-Ki positive patients with other diseases (P = 0.044 and P = 0.0003, respectively). Our study confirms a preferential occurrence of anti-Ki antibodies in patients with sicca and skin involvement. Malar rash and multiple ANA specificities were significantly associated with SLE compared to other diseases in our study. Anti-Ki were detected in 6% of patients with SLE with a significant prevalence in males.

Keywords

anti-ENA anti-Ki anti-SL Sjögren’s syndrome systemic lupus erythematosus

Get full access to this article

View all access options for this article.

References

Harmon C , Peebles C , Tan EM. SL - a new precipitating system . Arthritis Rheum 1981; 24(Suppl): S122-S122 (abstract).

Bernstein RM , Morgan SH , Bunn CC , Gainey RC , Hughes GRV , Mathews MB. The SL autoantibody-antigen system: clinical and biochemical studies . Ann Rheum Dis 1986; 45: 353-358 .

Tojo T , Kaburaki J , Hoyokawa M , Okamoto T , Tomii M , Homma M. Precipitating antibody to a soluble nuclear antigen ‘Ki’ with specificity for SLE . Ryumachi 1981; 21: 129-140 .

Nikaido T , Shimada K , Shibata M et al. Cloning and nucleotide sequence of cDNA for Ki antigen, a highly conserved nuclear protein detected with sera from patients with systemic lupus erythematosus . Clin Exp Immunol 1990; 79: 209-214 .

Takeuchi K , Kaneda K , Kawakami I , Takasaki Y , Hashimoto H. Autoantibodies recognizing proteins copurified with PCNA in patients with connective tissue diseases . Mol Biol Rep 1996; 23: 43-46 .

Takasaki Y , Kogure T , Takeuchi K et al. Reactivity of anti-proliferating cell nuclear antigen (PCNA) murine monoclonal antibodies and human autoantibodies to the PCNA multiprotein complexes involved in cell proliferation . J Immunol 2001; 166: 4780-4787 .

Matsudaira R , Takeuchi K , Takeuchi Y , Yano T , Matsushita M , Hashimoto H. Relationships between autoantibody responses to deletion mutants of Ki antigen and clinical manifestations of lupus . J Rheumatol 2003; 30: 1208-1214 .

Takasaki Y , Yano T , Hirokawa K et al. An epitope on Ki antigen recognized by autoantibodies from lupus patients shows homology with the SV 40 large T antigen nuclear localization signal . Arthritis Rheum 1996; 39: 855-862 .

Riboldi P , Asero R , Origgi L , Crespi S. The SL/Ki system in connective tissue diseases: incidence and clinical associations . Clin Exp Rheum 1987; 5: 29-33 .

10.

Boey ML , Peebles CL , Tsay G , Feng PH , Tan EM. Clinical and autoantibody correlations in Orientals with systemic lupus erythematosus . Ann Rheum Dis 1988; 47: 918-923 .

11.

Parodi A , Nigro A , Rebora A. Anti-SL/Ki antibody in a patients with a fatal connective tissue overlap disease . Br J Dermatol 1989; 121: 243-246 .

12.

Yamanaka K , Takasaki Y , Nishida Y , Shimada K , Shibata M , Hashimoto H. Detection and quantification of anti-Ki antibodies by enzyme-linked immunosorbent assay using recombinant Ki antigen . Arthritis Rheum 1992; 35: 667-671 .

13.

Sakamoto M , Takasaki Y , Yamanaka K , Kodama A , Hashimoto H , Hirose S. Purification and characterization of Ki antigen and detection of anti-Ki antibody by enzyme-linked immunosorbent assay in patients with systemic lupus erythematosus . Arthritis Rheum 1989; 32: 1554-1562 .

14.

Tan EM , Cohen AM , Fries JF et al. The 1982 revised criteria for the classification of systemic lupus erythematosus . Arthritis Rheum 1982; 25: 1271-1277 .

15.

Subcommittee for Scleroderma Criteria of the American Rheumatic Association Diagnostic and Therapeutic Criteria Committee . Preliminary criteria for the classification of systemic sclerosis (scleroderma) . Arthritis Rheum 1980; 23: 581-590 .

16.

Vitali C , Bombardieri S , Moutsopoulos HM et al. Assessment of European classification criteria for Sjögren’s syndrome in a series of clinically defined cases: results of a prospective multicentre study . Ann Rheum Dis 1996; 55: 116-121 .

17.

Mosca M , Neri R , Bombardieri S. Undifferentiated connective tissue diseases (UCTD): a review of the literature and a proposal for preliminary classification criteria . Clin Exp Rheumatol 1999; 17: 615-620 .

18.

Bohan A , Peter JB. Polymyositis and dermatomyositis . N Eng J Med 1975; 292: 344-347 .

19.

Alarcon-Segovia D , Cardiel MH. Comparison between 3 diagnostic criteria for mixed connective tissue disease. Study of 593 patients . J Rheumatol 1989; 16: 328-334 .

20.

Wilson WA , Gharavi AE , Koike T et al. International consensus statement on preliminary classification criteria for definite antiphospholipid syndrome: report of an international workshop . Arthritis Rheum 1999; 42: 1309-1311 .

21.

Bird HA , Esselinckx W , Dixon AS , Mowat AG , Wood PH. An evaluation of criteria for polymyalgia rheumatica . Ann Rheum Dis 1979; 38: 434-439 .

22.

Alvarez F , Berg PA , Bianchi FB et al. International autoimmune hepatitis group report: review of criteria for diagnosis of autoimmune hepatitis . J Hepatol 1999; 31: 929-938 .

23.

Harris EN. The second international anti-cardiolipin standardization workshop. The Kingston anti-phospholipid antibody study (KAPS) group . Ann J Clin Pathol 1990; 94: 476-484 .

24.

Balestrieri G , Tincani A , Spatola L et al.

Anti-ß2 glycoprotein I: a marker of antiphospholipid syndrome?

Lupus 1995; 4: 122-130 .

25.

Bernstein RM , Bunn CC , Hughes GRV. Identification of antibodies to acidic antigens by counterimmunoelectrophoresis . Ann Rheum Dis 1982; 41: 554-555 .

26.

Clark G , Reichlin M , Tomasi TB. Characterization of a soluble cytoplasmic antigen reactive with sera from patients with systemic lupus erythematosus . J Immunol 1969; 102: 117-122 .

27.

Venables PJW , Smith PR , Maini RN. Purification and characterization of the Sjögren’s Syndrome A and B antigens . Clin Exp Immunol 1983; 54: 731-738 .

28.

Matsunaga K. The “anti-Ki” syndrome: major clinical features . Rinsho Byori 1993; 41: 882-887 .

29.

Culp KS , Fleming CR , Duffy J , Baldus WP , Dickson ER. Autoimmune associations in primary biliary cirrhosis . Mayo Clin Proc 1982; 57: 365-370 .

30.

Matsumoto T , Kobayashi S , Shimizu H et al. The liver in collagen diseases: pathologic study of 160 cases with particular reference to hepatic arteritis, primary biliary cirrhosis, autoimmune hepatitis and nodular regenerative hyperplasia of the liver . Liver 2000; 20: 366-373 .

31.

Remmel T , Piirsoo A , Koiveer A et al. Clinical significance of different antinuclear antibodies patterns in the course of primary biliary cirrhosis . Hepatogastroenterology 1996; 43: 1135-1140 .

32.

Worman HJ , Courvalin JC. Antinuclear antibodies specific for primary biliary cirrhosis . Autoimmun Rev 2003; 2: 211-217 .

33.

Clark M , Sack K. Deforming arthropathy complicating primary biliary cirrhosis . J Rheumatol 1991; 18: 619-621 .

34.

Mackay IR. Hepatic disease and systemic lupus erythematosus: coincidence or convergence. In Lahita RG ed. Systemic lupus erythematosus, 3rd edn. San Diego, CA: Academic Press , 1999: 747-763.

35.

Mackay IR , Weiden S , Hasker J. Autoimmune hepatitis . Ann NY Acad Sci 1965; 124: 767-767 .

36.

Czaja AJ , Nishioka M , Morshed S , Hachiya T. Patterns of nuclear immunofluorescence and reactivities to recombinant nuclear antigens in autoimmune hepatitis . Gastroenterology 1994; 107: 200-207 .

37.

Penner E , Kindas-Mugge I , Hitchman E , Sauermann G. Nuclear antigens recognised by autoantibodies present in liver disease sera . Clin Exp Immunol 1986; 63: 428-433 .

38.

Omagari K , Ohba K , Kadokawa Y et al. Anti-extractable nuclear antigens (ENA) antibodies in patients with chronic hepatitis C before and after treatment with interferon . Autoimmunity 2003; 36: 269-273 .

39.

D’Amico E , Palazzi C , Cacciatore P et al. Anti-ENA antibodies in patients with chronic hepatitis C virus infection . Dig Dis Sci 2002; 47: 755-759 .

40.

Ramos-Casals M , Garcia-Carrasco M , Cervera R et al. Hepatitis C virus infection mimicking primary Sjögren’s syndrome. A clinical and immunologic description of 35 cases . Medicine (Baltimore) 2001; 80: 1-8 .

41.

Wakasugi M , Sato T , Maruyama Y , Ueno M , Arakawa M. A case of systemic erythematosus diagnosed 7 years after epileptic seizure and developed chorea during prednisolone treatment . Ryumachi 1996; 36: 545-550 .

42.

Francoeur AM , Peebles CL , Gompper ET , Tan EM. Identification of the Ki (Ku, p70/80) autoantigens and analysis of anti-Ki autoantibody reactivity . J Immunol 1986; 136: 1648-1653 .

43.

Mimori T , Suwa A , Hama N. Clinical significance of anti-Ku antibodies . Nippon Rinsho 1990; 48: 535-538 .

44.

Matsunaga K , Tsuji T , Satoh S , Ohta S , Tani K. The anti-Ki syndrome: clinical pictures. In Homma M , Sugai S , Tojo T , Miyasaka N , Akizuki M eds. Sjogren’s syndrome - state of the art. Amsterdam: Kugler , 1994: 583-584.